Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Medical Microinstruments Appoints Healthcare Industry Veteran Mark Toland as Chief Executive Officer 2021-01-12 23:00
Kira Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference 2021-01-12 22:57
Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories 2021-01-12 21:20
Aurabeat Launches FDA-cleared Air Purifier that Eliminates >99.9% of COVID-19 2021-01-12 21:09
Beactica Therapeutics and University of Dundee announce collaboration to develop WRN inhibitors to target cancer 2021-01-12 17:26
Techorizon announces the launch of the latest version of THeCRF 4.0 2021-01-12 17:00
PT Mowilex to Screen Its Workers with COVID-19 Tests from Abbott 2021-01-12 14:43
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer 2021-01-12 13:02
Zepp To Debut and Wow Consumers Worldwide at CES 2021 2021-01-12 13:00
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs 2021-01-12 12:26
Laneige Beauty & Life Lab hosted the first global symposium with retinol experts 2021-01-12 09:00
Gannex Announces Positive Phase I Clinical Results on Its THR-β Agonist ASC41 2021-01-12 08:30
DarwinHealth Scientists Publish Foundational Research Identifying Regulatory Mechanisms Controlling Cancer Cell States and Drug Response 2021-01-12 08:21
MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio 2021-01-12 04:38
Regent Pacific Announces Key Research Findings On FORTACIN™ 2021-01-11 23:36
Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services 2021-01-11 19:05
Amazfit Introduces the Ultra-fashionable Amazfit GTR 2e and GTS 2e Smartwatches with Cutting-edge Health and Fitness Features 2021-01-11 18:30
Airnov Made Its Debut at CPhI China 2021-01-11 16:26
Polygiene acquisition expands sustainable offering 2021-01-11 16:21
Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA. 2021-01-11 11:33
1 381 382 383 384 385 742